Sourasky Medical Center (Ichilov)
| イスラエル | トルコ | オーストリア | |
| 陽子線治療 | から $48,000 | から $70,000 | から $80,000 |
| 喉頭癌化学療法 | から $620 | から $5,000 | から $12,000 |
| 喉頭癌放射線治療 | - | から $3,250 | から $6,975 |
| 喉頭癌手術 | - | から $9,000 | から $30,000 |
| 喉頭摘出術 | - | から $8,000 | から $25,000 |
スーラスキー医療センターの軟部組織・骨腫瘍科部長 – メリムスキー教授は複雑な肉腫および喉頭癌を専門とする。
Dr. Yuri Goldes is a general surgeon with more than 20 years of clinical experience. He specializes in upper gastrointestinal and oncologic surgery. He is Deputy Director of the Department of General Surgery and Transplantation at Sheba Medical Center in Tel Aviv. He also leads the Upper GI Surgery Unit. He was named to Forbes Israel’s Best Doctors in 2025. He is ranked among Israel’s Best Gastrointestinal Surgeons by Forbes. In 2019, he received the Israeli Ministry of Health “Best Doctor of the Year” award.
He is an expert in advanced minimally invasive and robotic surgery. He treats diaphragmatic hernia, achalasia, GERD, and gallbladder disease. He also performs oncologic surgery for pancreatic, gastric, and esophageal cancers. He uses laparoscopic and robotic techniques.
He pioneered some of Israel’s first robotic oncologic resections of the stomach and pancreas. He is among a small group worldwide who perform minimally invasive Whipple procedures (pancreaticoduodenectomy) using advanced laparoscopy. He applies methods that improve outcomes and speed recovery. He provides personalized care.
Israeli clinics specialize in organ-preserving larynx cancer treatments. Surgeons prioritize voice preservation through Transoral Laser Microsurgery (TLM). Advanced cases receive multidisciplinary care. This includes IMRT radiation, biological therapies, and robotic surgery. Facilities like Sourasky Medical Center report a 90% success rate for oncology treatments.
Bookimed Expert Insight: Israeli oncology centers like Sheba Medical Center and Hadassah operate as massive multidisciplinary hubs. These facilities manage between 1,000,000 and 2,000,000 patients every year. This massive volume allows surgeons like Dr. Thomas Shpitzer at Assuta to maintain high proficiency in rare, minimally invasive techniques. Patients benefit from this collective experience through highly refined rehabilitation protocols and speech preservation strategies.
Patient Consensus: Patients emphasize the need to discuss voice preservation early. Many note that speech and swallowing therapy are essential for a successful recovery after surgery.
Israeli specialized centers report a 90% success rate for larynx preservation in oncology patients. Surgeons prioritize advanced techniques like transoral laser microsurgery and robotic surgery. These methods remove tumors with high precision while sparing vocal cords and surrounding healthy tissue to maintain functional speech.
Bookimed Expert Insight: Data shows that choosing academic centers like Sourasky or Sheba provides a distinct advantage. These facilities perform over 34,000 to 45,000 operations annually across all departments. This high volume allows surgeons to maintain rare expertise in complex partial laryngectomies. Such procedures are vital for patients who do not qualify for laser surgery but still wish to avoid a total voice box removal.
Patient Consensus: Patients note that early-stage diagnosis is key for better voice outcomes. They emphasize finding a specialist who focuses specifically on head and neck oncology rather than general surgery.
Israeli hospitals report a 90% success rate for radiotherapy and surgical procedures in treating larynx cancer. The overall 5-year survival rate reaches 88% at major tertiary facilities. Early detection remains a critical factor. Approximately 82% of Israeli cases are diagnosed during localized stages.
Bookimed Expert Insight: Sourasky Medical Center maintains a 90% average success rate for oncology. This high performance correlates with clinics like Sheba and Sourasky serving over 400,000 patients annually. Large patient volumes allow surgeons to specialize deeply. For example, Dr. Yuri Goldes at Sheba is recognized for robotic surgical innovation. High-volume centers often provide better outcomes in complex organ-preserving surgeries.
Patient Consensus: Patients note that stage at diagnosis is the strongest predictor of survival outcomes. They emphasize the importance of requesting specific data on voice and swallowing quality post-treatment.
Israeli hospitals provide advanced surgical technologies for larynx cancer, including Transoral Robotic Surgery (TORS) and Transoral Laser Microsurgery (TLM). These techniques allow surgeons to remove tumors through the mouth. This avoids external incisions and preserves vital vocal functions. Leading centers often report success rates around 90%.
Bookimed Expert Insight: Israeli oncology centers demonstrate high integration between surgical technology and recovery. Centers like Sheba and Sourasky perform over 30,000 surgeries annually. They combine robotic precision with immediate voice rehabilitation. Dr. Yuri Goldes at Sheba pioneered robotic resections now used in complex cases. This volume-based expertise ensures that even complex reconstructions maintain high functional outcomes.
Patient Consensus: Patients note it is important to choose centers with on-site rehabilitation specialists. They appreciate how robotic tools helped them speak clearly soon after surgery.